Antibacterial activity of Moringa oleifera leaves extract against vancomycin resistant Enterococcus faecalis Clinical Isolates
DOI:
https://doi.org/10.70882/jpas00579Keywords:
Antibacterial activity, antimicrobial resistance, Enterococcus faecalis, Moringa oleifera, phytochemicals.Abstract
Vancomycin-resistant Enterococcus faecalis (VRE) is a high-priority pathogen with limited treatment options. Medicinal plants offer promising alternatives due to their multi-target mechanisms. This study evaluated the antibacterial activity of Moringa oleifera leaf extract against VRE clinical isolates. Three Clinical isolates were phenotypically confirmed using Gram staining and biochemical tests. Vancomycin resistance was determined by disk diffusion. Ethanolic leaf extract was prepared, screened for phytochemical compounds and tested for antibacterial activity using agar well diffusion, broth microdilution (MIC), and minimum bactericidal concentration (MBC) assays. All the E. faecalis isolates (100%) were vancomycin-resistant (≤14 mm). Phytochemical screening of the M. oleifera ethanolic leaf extract revealed the presence of alkaloids, flavonoids, tannins, saponins, and steroids. The extract exhibited concentration-dependent inhibition against the VRE isolates with zones of inhibition ranging from 9–11 mm (25 mg/mL) to 20–24 mm (200 mg/mL). The MIC was 6.25 mg/mL and MBC was 12.5 mg/mL (MBC/MIC ratio = 2.0), indicating bactericidal activity. The M. oleifera leaf extract demonstrated significant bactericidal activity against phenotypically confirmed VRE, supporting its potential as an alternative therapeutic agent. Further studies on compound isolation, synergy, and in vivo efficacy are recommended.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Journal of Pure and Applied Sciences (Science Forum)

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.


